|
|
 |
|
Viewing report
|
|
 |
 |
Who’s Developing What in Drug Delivery?
Espicom Business Intelligence Ltd, Oct 2008, Pages: 680
The indispensable 2-volume guide to the companies that are shaping this critical area.
The importance of drug delivery technology grows ever more acute and commercial, and industry interest is continuing to build. The benefits to patients can be seen through improved medical outcomes, while the pharmaceutical industry is able to bring new products to market and extend patent protection through novel delivery regimes, and bring new therapies to the market that would previously have been impossible.
Consequently, the drug delivery sector has evolved from being simply a part of the pharmaceutical production process to a driving force for innovation and profits. As a result, developers of drug delivery products and technology have benefited from significant attention from customers and investors alike, and merger and acquisition activity is notable.
Who’s Developing What in Drug Delivery? is a new 680+ page management report (expanded 4th edition, published October 2008) that provides comprehensive analysis of 135 leading players in the drug delivery field.
“By 2015 sales of products using advanced drug delivery technology assessed could exceed US$43 billion.”
Key features and benefits...
- Detailed review of 134 leading companies in the field - Comprehensive coverage of each company’s technology focus, products, R&D and deals - International coverage – companies from across the world reviewed
All major drug-delivery technologies covered including: - Controlled-release - Nucleic acid - Nano-enabled - Targeted
Customers who bought this item also bought
Drug Delivery Partnering Agreements in Pharma and Biotech
Merger and Acquisition Agreements in Pharma, Biotech and Diagnostics, 2nd edition
Bigpharma Partnering Agreements
Manufacturing and Supply Agreements in Biopharma
Clinical Stage Partnering Agreements in Biopharma
Bigpharma Agreements Handbook 2007
Co-promotion and Co-marketing Agreements in Biopharma, 2nd Edition
Pre-clinical Stage Partnering Agreements in Biopharma
Who's Developing What in Cardiovascular Devices?
Personnel Staffing Agencies
Infectious Diseases Vaccine Market Overview: Key Companies & Strategies - In Times of Crisis, Big Pharma turns to Vaccines
HRT: Major Milestones - Current Perspectives on HRT and Menopause
|
 |
|
|